Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1039 | 2799 | 45.0 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
660 | 12667 | CYSTIC FIBROSIS//CFTR//JOURNAL OF CYSTIC FIBROSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CFTR | Author keyword | 179 | 35% | 15% | 419 |
2 | CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Author keyword | 159 | 44% | 10% | 273 |
3 | GREGORY FLEMING JAMES CYST FIBROSIS | Address | 82 | 58% | 3% | 94 |
4 | DELTA F508 CFTR | Author keyword | 35 | 89% | 1% | 16 |
5 | AIRWAY SURFACE LIQUID | Author keyword | 27 | 48% | 1% | 41 |
6 | F508DEL CFTR | Author keyword | 23 | 86% | 0% | 12 |
7 | CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR | Author keyword | 23 | 43% | 1% | 41 |
8 | CFTR CHLORIDE CHANNEL | Author keyword | 21 | 85% | 0% | 11 |
9 | CHLORIDE CHANNEL | Author keyword | 20 | 15% | 4% | 124 |
10 | CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE | Author keyword | 20 | 51% | 1% | 28 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANSMEMBRANE CONDUCTANCE REGULATOR | 386 | 28% | 43% | 1191 |
2 | CFTR | 316 | 41% | 21% | 598 |
3 | CFTR CHLORIDE CHANNEL | 213 | 77% | 5% | 147 |
4 | DELTA F508 CFTR | 208 | 74% | 6% | 154 |
5 | SMALL MOLECULE CORRECTORS | 195 | 91% | 3% | 81 |
6 | R DOMAIN | 176 | 71% | 5% | 141 |
7 | CL CHANNEL | 130 | 49% | 7% | 193 |
8 | CHLORIDE CHANNEL | 117 | 24% | 15% | 421 |
9 | CYSTIC FIBROSIS GENE | 57 | 19% | 10% | 272 |
10 | ANION SELECTIVITY | 56 | 57% | 2% | 66 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Origins of Cystic Fibrosis Lung Disease | 2015 | 8 | 69 | 59% |
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls | 2015 | 10 | 150 | 33% |
CFTR function and prospects for therapy | 2008 | 234 | 172 | 70% |
CFTR: folding, misfolding and correcting the Delta F508 conformational defect | 2012 | 77 | 95 | 87% |
The ABC protein turned chloride channel whose failure causes cystic fibrosis | 2006 | 279 | 82 | 71% |
Understanding how cystic fibrosis mutations disrupt CFTR function: From single molecules to animal models | 2014 | 12 | 108 | 87% |
Mechanisms of disease: Cystic fibrosis | 2005 | 542 | 57 | 37% |
New concepts of the pathogenesis of cystic fibrosis lung disease | 2004 | 320 | 95 | 56% |
Novel pharmacological strategies to treat cystic fibrosis | 2013 | 26 | 53 | 75% |
MOLECULAR MECHANISMS OF CFTR CHLORIDE CHANNEL DYSFUNCTION IN CYSTIC-FIBROSIS | 1993 | 855 | 21 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GREGORY FLEMING JAMES CYST FIBROSIS | 82 | 58% | 3.4% | 94 |
2 | PROGRAMME MOL STRUCT FUNCT | 17 | 68% | 0.5% | 15 |
3 | SC JOHNSON MED | 17 | 47% | 0.9% | 26 |
4 | CYST FIBROSIS | 15 | 13% | 3.8% | 107 |
5 | CYST FIBROSIS PULM TREATMENT | 14 | 18% | 2.4% | 67 |
6 | CYST FIBROSIS TREATMENT | 13 | 50% | 0.7% | 19 |
7 | CARDIAC MEMBRANE PHYSIOL | 12 | 50% | 0.6% | 18 |
8 | PHYSIOL BIOL CELLULAI | 9 | 21% | 1.3% | 37 |
9 | CYST FIBROSIS TRANSLAT | 8 | 100% | 0.2% | 5 |
10 | PEDIAT 0831 | 6 | 80% | 0.1% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000251804 | HUMAN MOL GENET PROGRAM//BAK FOONG PILL//EPITHELIAL CELL BIOL |
2 | 0.0000236105 | TRANSEPITHELIAL ELECTRICAL POTENTIAL DIFFERENCE//PATHOBIOCHEM CLIN CHEM//SWEAT GLAND |
3 | 0.0000169917 | GENE MED GRP//GENEMED GRP//EXPT TREATMENT CYST FIBROSIS |
4 | 0.0000159127 | ISOLATED PANCREATIC DUCT//PANCREATIC DUCT CELLS//PANCREATIC DUCT EPITHELIAL CELLS |
5 | 0.0000137883 | CYSTIC FIBROSIS//CFTR GENE//CBAVD |
6 | 0.0000116541 | TMEM16A//CALCIUM ACTIVATED CHLORIDE CHANNELS//CALCIUM ACTIVATED CHLORIDE CHANNEL |
7 | 0.0000095899 | RAT DISTAL COLON//CL SECRETION//CHLORIDE SECRETION |
8 | 0.0000084663 | CHLORIDE CURRENT//CALCIUM ACTIVATED CURRENT//CFTR INHIBITOR |
9 | 0.0000078779 | JOURNAL OF CYSTIC FIBROSIS//INHALED TOBRAMYCIN//PULMONARY EXACERBATION |
10 | 0.0000072735 | RHDNASE//DORNASE ALFA//MUCUS VISCOELASTICITY |